| Literature DB >> 12036364 |
Jing-Ping Liou1, Chun-Wei Chang, Jeng-Shin Song, Yung-Ning Yang, Ching-Fang Yeh, Huan-Yi Tseng, Yu-Kang Lo, Yi-Ling Chang, Chung-Ming Chang, Hsing-Pang Hsieh.
Abstract
A new type of inhibitor of tubulin polymerization was discovered on the basis of the combretastatin molecular skeleton. The lead compounds in this series, compounds 6 and 7, strongly inhibited tubulin polymerization in vitro and significantly arrested cells at the G(2)/M phase. Compounds 6 and 7 yielded 50- to 100-fold lower IC(50) values than did combretastatin A-4 against Colo 205, NUGC3, and HA22T human cancer cell lines as well as similar or greater growth inhibitory activities than did combretastain A-4 against DLD-1, HR, MCF-7, DU145, HONE-1, and MES-SA/DX5 human cancer cell lines. Structure-activity relationship information revealed that introduction of an amino group at the ortho position of the benzophenone ring plays an integral role for increased growth inhibition.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12036364 DOI: 10.1021/jm010365+
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446